Clinical Efficacy of Sleep Induction Intervention in Conjunction with Lorazepam in Managing Insomnia Disorder

Abstract

Background: This study investigates the clinical efcacy of a combined treatment approach involving sleep induction intervention and lorazepam in managing insomnia disorder.

Methods: This study enrolled a sample of 150 individuals diagnosed with insomnia disorder, consecutively admitted to our clinic from June 2021 to June 2023. Following randomization, the participants were divided into 2 groups: observation and control groups. Both groups were administered lorazepam treatment, with the observation group receiving sleep induction intervention and the control group receiving routine nursing. After the 4-week treatment period, relevant observation indicators were assessed to evaluate the efcacy of sleep improvement in both patient intervention groups.

Results: Compared to the control group that received only lorazepam treatment, the observation group, who underwent sleep induction intervention, showed a better treatment efectiveness rate, sleep quality, and psychological state regarding the treatment of sleep disorders (P < .05).

Conclusion: Sleep induction intervention can improve the overall treatment efectiveness rate of sleep disorders, enhance sleep quality, and alleviate symptoms of anxiety and depression.

Cite this article as: Chen J, Zhang Y, Min G, et al. Clinical efcacy of sleep induction intervention in conjunction with lorazepam in managing insomnia disorder. Psychiatry Clin Psychopharmacol. 2025;35(1):1-5.